US Stock MarketDetailed Quotes
ABBV AbbVie
- 185.160
- +2.990+1.64%
Close Jul 26 16:00 ET
- 185.000
- -0.160-0.09%
Post 20:01 ET
326.97BMarket Cap61.93P/E (TTM)
186.850High182.110Low6.95MVolume183.450Open182.170Pre Close1.29BTurnover0.39%Turnover Ratio68.07P/E (Static)1.77BShares186.85052wk High40.84P/B326.25BFloat Cap132.10252wk Low6.06Dividend TTM1.76BShs Float186.850Historical High3.27%Div YieldTTM2.60%Amplitude20.177Historical Low185.476Avg Price1Lot Size
AbbVie Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.31%14.46B | 0.70%12.31B | -6.44%54.32B | -5.42%14.3B | -5.97%13.93B | -4.92%13.87B | -9.70%12.23B | 3.30%58.05B | 1.58%15.12B | 3.28%14.81B |
| Operating revenue | 4.31%14.46B | 0.70%12.31B | -6.44%54.32B | -5.42%14.3B | -5.97%13.93B | -4.92%13.87B | -9.70%12.23B | 3.30%58.05B | 1.58%15.12B | 3.28%14.81B |
| Cost of revenue | -0.90%4.2B | 2.71%4.09B | 17.23%20.42B | 36.79%5.7B | 29.13%6.49B | 1.68%4.24B | -1.63%3.99B | -0.18%17.41B | -3.47%4.17B | 14.40%5.02B |
| Gross profit | 6.60%10.26B | -0.28%8.22B | -16.58%33.9B | -21.50%8.6B | -23.98%7.44B | -7.57%9.63B | -13.15%8.24B | 4.87%40.64B | 3.64%10.95B | -1.63%9.79B |
| Operating expense | 10.20%5.33B | -1.26%5.25B | -6.68%20.37B | -1.65%5.12B | -1.01%5.1B | -29.45%4.83B | 15.07%5.32B | 10.78%21.83B | 2.34%5.21B | -1.85%5.15B |
| Selling and administrative expenses | 3.34%3.38B | 9.08%3.32B | -15.65%12.87B | -6.56%3.19B | 2.06%3.37B | -39.62%3.27B | -2.81%3.04B | 23.57%15.26B | 4.82%3.42B | 7.17%3.3B |
| Research and development costs | 12.41%1.95B | -15.40%1.94B | 17.90%7.68B | 7.65%1.93B | 6.75%1.72B | 7.71%1.73B | 53.11%2.29B | -5.95%6.51B | -2.03%1.79B | -2.83%1.61B |
| Other operating expenses | ---- | ---- | -419.64%-179M | --0 | ---- | 1.74%-169M | ---10M | -87.04%56M | ---1M | -54.20%229M |
| Operating profit | 2.96%4.94B | 1.51%2.96B | -28.06%13.54B | -39.48%3.48B | -49.45%2.35B | 34.48%4.79B | -39.98%2.92B | -1.23%18.81B | 4.85%5.75B | -1.38%4.64B |
| Net non-operating interest income expense | -11.45%-506M | 0.22%-453M | 17.61%-1.68B | 20.59%-378M | 19.92%-398M | 14.66%-454M | 15.77%-454M | 14.26%-2.04B | 16.64%-476M | 15.04%-497M |
| Non-operating interest income | ---- | 109.09%207M | 190.32%540M | 106.67%186M | 149.21%157M | 308.33%98M | 1,000.00%99M | 376.92%186M | 900.00%90M | 472.73%63M |
| Non-operating interest expense | -8.33%506M | 19.35%660M | -0.27%2.22B | -0.35%564M | -0.89%555M | -0.72%552M | 0.91%553M | -7.97%2.23B | -2.41%566M | -6.04%560M |
| Other net income (expense) | -32.04%-2.28B | 62.09%-754M | -70.09%-5.6B | 18.10%-1.89B | -98.43%4M | 6.49%-1.73B | -428.22%-1.99B | 10.39%-3.29B | -261.70%-2.3B | 158.39%254M |
| Gain on sale of security | 97.30%-1M | 88.57%-4M | 1.35%-146M | -22.50%-49M | 30.56%-25M | 21.28%-37M | -40.00%-35M | -190.20%-148M | -150.00%-40M | -200.00%-36M |
| Special income (charges) | -234.64%-937M | -9.33%-164M | -11.62%-778M | -16.05%-282M | -65.00%-66M | -4.09%-280M | -3.45%-150M | 37.99%-697M | 40.00%-243M | 90.05%-40M |
| -Less：Restructuring and merger&acquisition | --937M | 9.33%164M | ---- | ---- | ---- | ---- | --150M | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | 11.62%778M | 16.05%282M | 65.00%66M | 4.09%280M | ---- | -37.99%697M | -40.00%243M | -90.05%40M |
| Other non- operating income (expenses) | 4.75%-1.35B | 67.52%-586M | -91.05%-4.68B | 23.01%-1.56B | -71.21%95M | 7.89%-1.41B | -332.47%-1.8B | 2.08%-2.45B | -835.65%-2.02B | 1,671.43%330M |
| Income before tax | -17.78%2.15B | 269.47%1.76B | -53.62%6.25B | -59.12%1.21B | -55.61%1.95B | 120.63%2.61B | -90.36%475M | 3.76%13.48B | -30.58%2.97B | 19.31%4.4B |
| Income tax | 32.59%773M | 63.68%383M | -15.63%1.38B | -21.30%388M | -61.61%172M | 128.63%583M | -46.33%234M | 13.33%1.63B | 118.14%493M | -11.81%448M |
| Net income | -32.26%1.37B | 469.29%1.37B | -58.86%4.87B | -66.67%824M | -54.93%1.78B | 118.43%2.03B | -94.64%241M | 2.56%11.85B | -38.89%2.47B | 24.28%3.95B |
| Net income continuous Operations | -32.26%1.37B | 469.29%1.37B | -58.86%4.87B | -66.67%824M | -54.93%1.78B | 118.43%2.03B | -94.64%241M | 2.56%11.85B | -38.89%2.47B | 24.28%3.95B |
| Minority interest income | 0.00%3M | 50.00%3M | 11.11%10M | 300.00%2M | 0.00%3M | -25.00%3M | -33.33%2M | 28.57%9M | -200.00%-1M | 200.00%3M |
| Net income attributable to the parent company | -32.31%1.37B | 472.80%1.37B | -58.91%4.86B | -66.76%822M | -54.98%1.78B | 119.05%2.02B | -94.68%239M | 2.55%11.84B | -38.85%2.47B | 24.22%3.95B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | -9.09%10M | -20.37%43M | 0.00%11M | -50.00%11M | -27.03%54M | |||||
| Net income attributable to common stockholders | -31.94%1.37B | 496.05%1.36B | -59.09%4.82B | -67.80%779M | -54.98%1.78B | 120.48%2.01B | -94.90%228M | 2.74%11.78B | -39.87%2.42B | 25.05%3.95B |
| Basic earnings per share | -31.95%0.7758 | 492.31%0.77 | -58.95%2.73 | -66.70%0.4655 | -54.95%1 | 119.23%1.14 | -94.84%0.13 | 2.62%6.65 | -38.88%1.3978 | 24.72%2.22 |
| Diluted earnings per share | -32.46%0.77 | 492.31%0.77 | -58.97%2.72 | -66.67%0.46 | -54.75%1 | 123.53%1.14 | -94.82%0.13 | 2.79%6.63 | -38.94%1.38 | 24.16%2.21 |
| Dividend per share | 4.73%1.55 | 4.73%1.55 | 4.96%5.92 | 4.96%1.48 | 4.96%1.48 | 4.96%1.48 | 4.96%1.48 | 8.46%5.64 | 8.46%1.41 | 8.46%1.41 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg